Events

Recall of CENTRIMAG EXTRACORPOREAL BLOOD PUMPING SYSTEM - CONSOLE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by THORATEC SWITZERLAND GMBH.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    122231
  • Event Risk Class
    II
  • Event Initiated Date
    2008-04-01
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Interruption of centrimag system support may occur when using a valleylab force fx-c electrocautery unit.

Device

CENTRIMAG EXTRACORPOREAL BLOOD PUMPING SYSTEM - CONSOLE
  • Model / Serial
    Model Catalog: 201-90220 (Lot serial: All Serial Numbers); Model Catalog: 201-90160 (Lot serial: All Serial Numbers)
  • Product Description
    Levitronix CentriMag Systems
  • Manufacturer
    THORATEC SWITZERLAND GMBH

Manufacturer

THORATEC SWITZERLAND GMBH
  • Manufacturer Address
    ZURICH
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    HC